Peptide Pen Nerve Repair
ARA-290 (Cibinetide) is a synthetic peptide developed from a specific region of erythropoietin (EPO) and is widely researched for its potential role in nerve regeneration, tissue repair, and neuroprotective pathways. Supplied in a 50mg peptide pen format, ARA-290 is investigated for its involvement in peripheral nerve health, remyelination, and inflammatory signalling.
Originally developed for tissue-protection research without the erythropoietic effects associated with full erythropoietin, ARA-290 has become a recognised peptide in neuroscience, regenerative medicine, and neuropathy-focused investigations.
💡 Features & Benefits
- 50mg ARA-290 (Cibinetide) peptide pen formulation
- Research focus on nerve regeneration pathways
- Investigated for neuroprotective signalling
- Studied for remyelination research
- Associated with tissue repair and recovery investigations
- Research interest in inflammatory pathway modulation
- Studied for peripheral nerve wellness research
- Convenient peptide pen format for laboratory applications
🧬 Research Focus
ARA-290 has been researched for its potential role in:
- Peripheral nerve regeneration
- Neuroprotective pathways
- Remyelination research
- Tissue repair and recovery
- Neuropathic pain investigations
- Inflammatory signalling pathways
- Sensory nerve function research
- Regenerative medicine studies
Its investigational profile has made ARA-290 one of the most recognised peptides in neuroscience and regenerative medicine research.
🔬 How ARA-290 Works
ARA-290 is researched for its interaction with the innate repair receptor (IRR), a receptor complex involved in tissue protection and cellular repair. Activation of this pathway has been investigated for its potential role in supporting nerve repair, reducing inflammatory signalling, and promoting regenerative processes.
Research has explored its potential role in:
- Nerve regeneration pathways
- Remyelination research
- Neuroprotective signalling
- Tissue repair investigations
- Peripheral nerve function studies
- Inflammatory pathway modulation
Unlike full erythropoietin, ARA-290 is studied as a targeted peptide that focuses on tissue-protective and regenerative signalling without stimulating red blood cell production.
🧪 Handling & Use
- For research use only.
- Handle according to sterile laboratory procedures.
- Store according to packaging instructions.
- Use only in controlled research environments.
⚠️ Important Information
- Not approved for human consumption.
- Not intended for therapeutic or medical use.
- This product is supplied strictly for research purposes only.
🔐 Disclaimer
The information provided is intended strictly for educational and informational purposes only and should not be considered medical advice.
By purchasing this product, you acknowledge that:
- You have independently researched this product and its investigational status.
- This product is intended for research use only.
- The seller provides no medical advice, treatment claims, or dosing guidance.
- Responsibility for lawful and appropriate use rests entirely with the purchaser.
Research Use Notice
For laboratory and research purposes only. Not for human consumption.
This product is not a medicine, has not been evaluated or approved by SAHPRA for safety, quality, or efficacy, and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. Any research areas referenced above relate to published scientific literature and general research interest — they are not guaranteed outcomes and do not constitute claims about what this product will do if used.
Grownova does not manufacture, import, or hold stock of this product. It is supplied directly by licensed third-party laboratories and is sold strictly for lawful laboratory, analytical, or research purposes only. Self-administration is strongly discouraged. Always consult a qualified healthcare professional before considering any research compound.